Average Co-Inventor Count = 4.67
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Genentech, Inc. (9 from 3,224 patents)
2. Kalypsys, Inc. (7 from 17 patents)
3. Metacrine, Inc. (7 from 8 patents)
4. Seragon Pharmaceuticals, Inc. (6 from 6 patents)
5. Aragon Pharmaceuticals, Inc. (2 from 34 patents)
6. Merck + Co., Inc. (1 from 4,770 patents)
7. Merck Sharp + Dohme Corp. (1 from 2,405 patents)
8. Alcon Laboratories, Inc. (1 from 449 patents)
9. Organovo, Inc. (1 from 31 patents)
10. Eli Lilly and Company (4,449 patents)
11. F. Hoffmann-La Roche Ag (168 patents)
34 patents:
1. 11773094 - Farnesoid X receptor agonists and uses thereof
2. 11236071 - Farnesoid X receptor agonists and uses thereof
3. 11214538 - Farnesoid X receptor agonists and uses thereof
4. 11084817 - Farnesoid X receptor agonists and uses thereof
5. 10961198 - Farnesoid X receptor agonists and uses thereof
6. 10703712 - Farnesoid X receptor agonists and uses thereof
7. 10626081 - Farnesoid X receptor agonists and uses thereof
8. 10377717 - Farnesoid X receptor agonists and uses thereof
9. 10227334 - Estrogen receptor modulators and uses thereof
10. 10053451 - Heterocyclic estrogen receptor modulators and uses thereof
11. 9873684 - Estrogen receptor modulators and uses thereof
12. 9868704 - Estrogen receptor modulators and uses thereof
13. 9845291 - Estrogen receptor modulators and uses thereof
14. 9655880 - Azetidine estrogen receptor modulators and uses thereof
15. 9586952 - Polycyclic estrogen receptor modulators and uses thereof